BCL2L11 and prostate cancer: There are also numerous publications reporting mRNAs containing retained intronic sequences, including the retention of CD44 introns in bladder cancer (Cooper, 1995), and the recently-described upregulation of the novel proapoptotic BH3-only splice variant of BIM in prostate cancer cells (Liu et al, 2002).